Enovis reports Q2 2026 sales of $583 million, reaffirms 2026 guidance

Enovis reported Q2 2026 sales of $583 million, up 3% reported and 5% organic. Recon segment grew 6% organically on hips and knees; P&R grew 3% organically. The company reaffirmed its 2026 guidance, expecting sales acceleration in Q4.

Detected & updated continuously · Source: Nebula